Outcome of Transcatheter Atrial Septal Defect Closure in a Nationwide Cohort

Overview

Journal Ann Med

Publisher Informa Healthcare

Specialty General Medicine

Date 2023 Feb 14

PMID 36786506

Authors

V Muroke

M Jalanko

J Haukka

J Hartikainen

A Tahvanainen

H Ukkonen

K Ylitalo

J Pihkala

J Sinisalo

Affiliations

Soon will be listed here.

Abstract

Background: Transcatheter (TC) atrial septal defect (ASD) closure has been the mainstay of therapy for secundum-type ASDs for over 20 years.

Aims: This nationwide cohort evaluated the long-term outcome of transcatheter-closed ASDs.

Methods: The study enrolled every transcatheter ASD closure performed in Finland from 1999 to 2019. Five age, sex, and municipality-matched controls per ASD patient were gathered from the general population. The median follow-up period was 5.9 years (range 0-20.8). We used the hospital discharge register to gather all hospital visits and diagnoses. Closure complications and echocardiographic changes were collected from the electronic health records.

Results: Transcatheter ASD closure was performed in 1000 patients (68.5% females) during the study period. The median (range) age at the time of the procedure was 37.9 (1.8-87.5) years. ASD patients had an increased risk for new-onset atrial fibrillation (RR 2.45, 95% CI: 1.84-3.25), migraine (RR 3.61, 95% CI: 2.54-5.14), ischemic heart disease (RR 1.73, 95% CI: 1.23-2.45), ventricular fibrillation/tachycardia (RR 3.54 (95% CI: 1.48-8.43) and AV conduction disorder (RR 3.60, 95% CI: 1.94-6.70) compared to the control cohort. Stroke risk was not increased (RR 1.36, 95% CI: 0.91-2.03). Adverse events occurred in 6.3% ( = 63) of the patients, including four erosions and ten device embolizations.

Conclusion: After TC closure of ASD, patients had a higher risk of new-onset atrial fibrillation and migraine . As novel findings, we found an increased risk for ischemic heart disease, AV conduction disorders, and ventricular fibrillation/tachycardia.Key messagesEven though patients have an excellent overall prognosis after percutaneous ASD closure, the increased incidence of major comorbidities like atrial fibrillation and heart failure prompts more thorough lifelong follow-up.This study's novel findings revealed the increased risk for ischemic heart disease, AV conduction disorders, or ventricular tachycardia/fibrillation during the follow-up.Major complications after the closure are rare; erosion is seen in 0.4% of the patients and embolization in 1.0% of the patients.

Citing Articles

Percutaneous atrial septal defect closure in limited-resource setting: a decade-long experience from Ethiopia.

Nasir M, Dejene K, Bedru M, Markos S Front Cardiovasc Med. 2025; 12:1550693.

PMID: 40041170 PMC: 11876549. DOI: 10.3389/fcvm.2025.1550693.

Long-term outcomes of transcatheter atrial septal defect closure: a single-center retrospective study.

Honghiranrueng L, Roymanee S, Wongwaitaweewong K, Jarutach J, Buntharikpornpun R Front Cardiovasc Med. 2024; 11:1448967.

PMID: 39280031 PMC: 11392770. DOI: 10.3389/fcvm.2024.1448967.

Secundum atrial septal defect closure in adults in the UK.

English K, Espuny-Pujol F, Franklin R, Crowe S, Pagel C Eur Heart J Qual Care Clin Outcomes. 2024; 11(1):78-88.

PMID: 38479784 PMC: 11736148. DOI: 10.1093/ehjqcco/qcae019.

Arrhythmic Risk and Treatment after Transcatheter Atrial Septal Defect Closure.

Deaconu S, Deaconu A, Marascu G, Stanculescu M, Cozma D, Cinteza E Diagnostics (Basel). 2024; 14(1).

PMID: 38201344 PMC: 10795847. DOI: 10.3390/diagnostics14010033.

Volume overload impedes the maturation of sarcomeres and T-tubules in the right atria: a potential cause of atrial arrhythmia following delayed atrial septal defect closure.

Dong Z, Chen D, Zheng S, Wang Z, Li D, Xiao Y Front Physiol. 2023; 14:1237187.

PMID: 37908335 PMC: 10614073. DOI: 10.3389/fphys.2023.1237187.

References

Jalal Z, Hascoet S, Baruteau A, Iriart X, Kreitmann B, Boudjemline Y . Long-term Complications After Transcatheter Atrial Septal Defect Closure: A Review of the Medical Literature. Can J Cardiol. 2016; 32(11):1315.e11-1315.e18. DOI: 10.1016/j.cjca.2016.02.068. View

Hiraishi M, Tanaka H, Motoji Y, Sawa T, Tsuji T, Miyoshi T . Impact of Right Ventricular Geometry on Mitral Regurgitation After Transcatheter Closure of Atrial Septal Defect. Int Heart J. 2015; 56(5):516-21. DOI: 10.1536/ihj.15-073. View

Giannakoulas G, Dimopoulos K, Engel R, Goktekin O, Kucukdurmaz Z, Vatankulu M . Burden of coronary artery disease in adults with congenital heart disease and its relation to congenital and traditional heart risk factors. Am J Cardiol. 2009; 103(10):1445-50. DOI: 10.1016/j.amjcard.2009.01.353. View

Himelfarb J, Shulman H, Olesovsky C, Rumman R, Oliva L, Friedland J . Atrial fibrillation following transcatheter atrial septal defect closure: a systematic review and meta-analysis. Heart. 2021; 108(15):1216-1224. DOI: 10.1136/heartjnl-2021-319794. View

Udholm S, Nyboe C, Redington A, Nielsen-Kudsk J, Nielsen J, Hjortdal V . Hidden burden of arrhythmias in patients with small atrial septal defects: a nationwide study. Open Heart. 2019; 6(1):e001056. PMC: 6609115. DOI: 10.1136/openhrt-2019-001056. View

Wertman B, Azarbal B, Riedl M, Tobis J . Adverse events associated with nickel allergy in patients undergoing percutaneous atrial septal defect or patent foramen ovale closure. J Am Coll Cardiol. 2006; 47(6):1226-7. DOI: 10.1016/j.jacc.2005.12.017. View

Butera G, Romagnoli E, Carminati M, Chessa M, Piazza L, Negura D . Treatment of isolated secundum atrial septal defects: impact of age and defect morphology in 1,013 consecutive patients. Am Heart J. 2008; 156(4):706-12. DOI: 10.1016/j.ahj.2008.06.008. View

Faccini A, Butera G . Atrial septal defect (ASD) device trans-catheter closure: limitations. J Thorac Dis. 2018; 10(Suppl 24):S2923-S2930. PMC: 6174146. DOI: 10.21037/jtd.2018.07.128. View

El-Said H, Hegde S, Foerster S, Hellenbrand W, Kreutzer J, Trucco S . Device therapy for atrial septal defects in a multicenter cohort: acute outcomes and adverse events. Catheter Cardiovasc Interv. 2014; 85(2):227-33. DOI: 10.1002/ccd.25684. View

10.

Abaci A, Unlu S, Alsancak Y, Kaya U, Sezenoz B . Short and long term complications of device closure of atrial septal defect and patent foramen ovale: meta-analysis of 28,142 patients from 203 studies. Catheter Cardiovasc Interv. 2013; 82(7):1123-38. DOI: 10.1002/ccd.24875. View

11.

Ghosh S, Chatterjee S, Black E, Firmin R . Surgical closure of atrial septal defects in adults: effect of age at operation on outcome. Heart. 2002; 88(5):485-7. PMC: 1767414. DOI: 10.1136/heart.88.5.485. View

12.

Yalonetsky S, Horlick E, Osten M, Benson L, Oechslin E, Silversides C . Clinical characteristics of coronary artery disease in adults with congenital heart defects. Int J Cardiol. 2011; 164(2):217-20. DOI: 10.1016/j.ijcard.2011.07.021. View

13.

Nyboe C, Olsen M, Nielsen-Kudsk J, Hjortdal V . Atrial fibrillation and stroke in adult patients with atrial septal defect and the long-term effect of closure. Heart. 2015; 101(9):706-11. DOI: 10.1136/heartjnl-2014-306552. View

14.

DiBardino D, McElhinney D, Kaza A, Mayer Jr J . Analysis of the US Food and Drug Administration Manufacturer and User Facility Device Experience database for adverse events involving Amplatzer septal occluder devices and comparison with the Society of Thoracic Surgery congenital cardiac surgery.... J Thorac Cardiovasc Surg. 2009; 137(6):1334-41. PMC: 4230527. DOI: 10.1016/j.jtcvs.2009.02.032. View

15.

Asakai H, Weskamp S, Eastaugh L, dUdekem Y, Pflaumer A . Atrioventricular block after ASD closure. Heart Asia. 2016; 8(2):26-31. PMC: 4975855. DOI: 10.1136/heartasia-2016-010745. View

16.

Duong P, Ferguson L, Lord S, Murray S, Shepherd E, Bourke J . Atrial arrhythmia after transcatheter closure of secundum atrial septal defects in patients ≥40 years of age. Europace. 2016; 19(8):1322-1326. DOI: 10.1093/europace/euw186. View

17.

Wintzer-Wehekind J, Horlick E, Ibrahim R, Barriault A, Cote M, Osten M . Impact of Atrial Septal Defect Closure on Migraine Headaches: Results From a Multicenter Prospective Registry. Circ Cardiovasc Interv. 2020; 13(11):e009841. DOI: 10.1161/CIRCINTERVENTIONS.120.009841. View

18.

Takaya Y, Akagi T, Kijima Y, Nakagawa K, Sano S, Ito H . Long-term outcome after transcatheter closure of atrial septal defect in older patients: impact of age at procedure. JACC Cardiovasc Interv. 2015; 8(4):600-6. DOI: 10.1016/j.jcin.2015.02.002. View

19.

Wilson N, Smith J, Prommete B, ODonnell C, Gentles T, Ruygrok P . Transcatheter closure of secundum atrial septal defects with the Amplatzer septal occluder in adults and children-follow-up closure rates, degree of mitral regurgitation and evolution of arrhythmias. Heart Lung Circ. 2008; 17(4):318-24. DOI: 10.1016/j.hlc.2007.10.013. View

20.

Du Z, Hijazi Z, Kleinman C, Silverman N, Larntz K . Comparison between transcatheter and surgical closure of secundum atrial septal defect in children and adults: results of a multicenter nonrandomized trial. J Am Coll Cardiol. 2002; 39(11):1836-44. DOI: 10.1016/s0735-1097(02)01862-4. View